200 related articles for article (PubMed ID: 27509160)
1. Severe Colitis Associated with Pirfenidone Use in Idiopathic Pulmonary Fibrosis.
Fiddler CA; Simler N; Parfrey H; Miremadi A; Chilvers ER
Ann Am Thorac Soc; 2016 Aug; 13(8):1430-2. PubMed ID: 27509160
[No Abstract] [Full Text] [Related]
2. Is pirfenidone effective for idiopathic pulmonary fibrosis?
Jeldres A; Labarca G
Medwave; 2017 Jan; 17(Suppl1):e6843. PubMed ID: 28112713
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis].
Tokura T; Oku H; Tsukamoto Y
Nihon Yakurigaku Zasshi; 2009 Aug; 134(2):97-104. PubMed ID: 19672005
[No Abstract] [Full Text] [Related]
4. Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
Loeh B; Drakopanagiotakis F; Bandelli GP; von der Beck D; Tello S; Cordani E; Rizza E; Barrocu L; Markart P; Seeger W; Guenther A; Albera C
Am J Respir Crit Care Med; 2015 Jan; 191(1):110-3. PubMed ID: 25551350
[No Abstract] [Full Text] [Related]
5. Pirfenidone for idiopathic pulmonary fibrosis.
Bouros D
Lancet; 2011 May; 377(9779):1727-9. PubMed ID: 21571363
[No Abstract] [Full Text] [Related]
6. Reactivation pulmonary tuberculosis in two patients treated with pirfenidone.
Khan M; Alghamdi M; Al-Jahdali H
Int J Mycobacteriol; 2017; 6(2):193-195. PubMed ID: 28559525
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone.
Richeldi L; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2011 Jul; 10(7):489-90. PubMed ID: 21837822
[No Abstract] [Full Text] [Related]
8. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
[TBL] [Abstract][Full Text] [Related]
9. Perils with Pirfenidone and "the tuberculosis link".
Hande MH; Acharya KV; Shreenivasa A; Nayak K; Arun S
Int J Mycobacteriol; 2019; 8(3):298-301. PubMed ID: 31512609
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study.
Tzouvelekis A; Ntolios P; Karampitsakos T; Tzilas V; Anevlavis S; Bouros E; Steiropoulos P; Koulouris N; Stratakos G; Froudarakis M; Bouros D
Pulm Pharmacol Ther; 2017 Oct; 46():48-53. PubMed ID: 28843616
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone-induced phototoxic reaction in a patient with idiopathic pulmonary fibrosis.
Woo YJ; Sohn KM; Kang H; Kim JE
Eur J Dermatol; 2017 Oct; 27(5):545-546. PubMed ID: 29084642
[No Abstract] [Full Text] [Related]
12. [Idiopathic pulmonary fibrosis: treatment with pirfenidone].
Cano-Jiménez E
Arch Bronconeumol; 2012 Oct; 48 Suppl 2():16-8. PubMed ID: 23630972
[No Abstract] [Full Text] [Related]
13. Pirfenidone photosensitization in patients with idiopathic pulmonary fibrosis: a case series.
Droitcourt C; Adamski H; Polat A; Polard E; Kerjouan M; Arnouat B; Le Garrec M; Oger E; Dupuy A; Jouneau S
Br J Dermatol; 2018 Mar; 178(3):e222-e223. PubMed ID: 28963722
[No Abstract] [Full Text] [Related]
14. Pirfenidone-Induced Sarcoid-Like Reaction: A Novel Complication.
Kolaitis NA; Kukreja J; Jones KD; Hays SR; Leard LE
Chest; 2018 Oct; 154(4):e89-e92. PubMed ID: 30290953
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis.
Sathiyamoorthy G; Sehgal S; Ashton RW
South Med J; 2017 Jun; 110(6):393-398. PubMed ID: 28575896
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pulmonary fibrosis and pirfenidone.
Collard HR
Eur Respir J; 2010 Apr; 35(4):728-9. PubMed ID: 20356985
[No Abstract] [Full Text] [Related]
17. A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Anderson A; Shifren A; Nathan SD
Expert Opin Drug Saf; 2016 Jul; 15(7):975-82. PubMed ID: 27177012
[TBL] [Abstract][Full Text] [Related]
18. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis.
Arai T; Inoue Y; Sasaki Y; Tachibana K; Nakao K; Sugimoto C; Okuma T; Akira M; Kitaichi M; Hayashi S
Respir Investig; 2014 Mar; 52(2):136-43. PubMed ID: 24636270
[TBL] [Abstract][Full Text] [Related]
19. A rare case of drug-induced hypersensitivity syndrome by pirfenidone for idiopathic pulmonary fibrosis.
Suda K; Kamiya K; Chiang B; Okada H; Mato N; Maekawa T; Komine M; Murata S; Ohtsuki M
Allergol Int; 2018 Jul; 67(3):425-426. PubMed ID: 29588165
[No Abstract] [Full Text] [Related]
20. [Patient treated with pirfenidone].
Valenzuela C
Arch Bronconeumol; 2012 Oct; 48 Suppl 2():19-20. PubMed ID: 23630973
[No Abstract] [Full Text] [Related]
[Next] [New Search]
